Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9327394 | Gynecologic Oncology | 2005 | 11 Pages |
Abstract
S-LMP and S-Ca are distinguished at the molecular level by a relatively small gene set, suggesting the pathogenesis of S-LMP as well as S-Ca may involve molecular pathways that escape detection by global gene expression profiling. In order to obtain biologically and clinically relevant information about the mechanisms involved in ovarian carcinogenesis, future studies based on molecular profiles of ovarian cancer should include analyses of low malignant potential tumors. Inclusion of such tumors is also critical to the evaluation of the efficacy of potential new diagnostic and/or therapeutic biomarkers.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
C. Blake Gilks, Barbara C. Vanderhyden, Shirley Zhu, Matt van de Rijn, Teri A. Longacre,